Myeloperoxidase levels predicts angiographic severity of coronary artery disease in patients with chronic stable angina
Open Access
- 1 January 2014
- journal article
- Published by Medknow in Advanced Biomedical Research
- Vol. 3 (1) , 139
Abstract
Myeloperoxidase (MPO) has an important role in the both processes of inflammation and oxidative stress. It plays proatherogenic role via low-density lipoprotein oxidation, functional inactivation of the high-density lipoprotein and endothelial dysfunction, and seems to be involved in the atherogenesis of coronary arteries. This study designed to evaluate the association between the plasma MPO levels and angiographic severity of coronary artery disease (CAD) in patients with the stable CAD. Sixty-eight patients who had documented CAD with angiography and 66 subjects who had normal angiography were selected as case and the control groups for this study, respectively. Gensini scoring system was used for evaluation of severity of coronary artery stenosis. Plasma MPO and C-reactiveprotein (CRP) levels of both case and control groups were determined. Plasma MPO levels and CRP levels were significantly higher in CAD patients (P < 0.001), and plasma levels of MPO and CRP were correlated with Genssini scores. Our findings indicated that the plasma MPO levels increase in patients with stable CAD and hence that, it can be used as adiagnostic factor to predict the coronary artery atherosclerosis severity in stable CAD patients; However, it needs further widespread investigations to achieve an accurate cut point.Keywords
This publication has 37 references indexed in Scilit:
- Myeloperoxidase Targets Apolipoprotein A-I, the Major High Density Lipoprotein Protein, for Site-Specific Oxidation in Human Atherosclerotic LesionsJournal of Biological Chemistry, 2012
- Plasma Myeloperoxidase Predicts Incident Cardiovascular Risks in Stable Patients Undergoing Medical Management for Coronary Artery DiseaseClinical Chemistry, 2011
- Correlation between high density lipoprotein-cholesterol and remodeling index in patients with coronary artery disease: IDEAS (IVUS diagnostic evaluation of atherosclerosis in Singapore)-HDL studyThe International Journal of Cardiovascular Imaging, 2011
- Myeloperoxidase and C-Reactive Protein Have Combined Utility for Long-Term Prediction of Cardiovascular Mortality After Coronary AngiographyJACC, 2010
- Inflammatory biomarkers, physical activity, waist circumference, and risk of future coronary heart disease in healthy men and womenEuropean Heart Journal, 2009
- Plasma levels of myeloperoxidase are not elevated in patients with stable coronary artery diseaseClinica Chimica Acta, 2008
- Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18European Heart Journal, 2008
- Serum Myeloperoxidase Levels Are Associated With the Future Risk of Coronary Artery Disease in Apparently Healthy IndividualsJACC, 2007
- Myeloperoxidase and Plaque VulnerabilityArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions.Journal of Clinical Investigation, 1994